KEYMED BIO-B

02162

----

Current ValuationThe current P/E ratio is 22.96, above the reasonable range, cheaper than 6.39% of the time in the past 3 years, and the industry ranks 16/78, the industry Median -4.65.

22.96xP/E

Stock priceHK$68.45Earnings per shareHK$2.98

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0152304456608

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
02696HKHENLIUS	27.23x	28.41%	HK$27.19B
02162HKKEYMED BIO-B	22.96x	249.12%	HK$20.45B
02157HKLEPU BIO	18.81x	127.52%	HK$5.35B
06826HKHAOHAI BIOTEC	28.82x	128.83%	HK$3.67B
02181HKMABPHARM-B	19.46x	--	HK$1.92B
06915HKJIANGXI BIO	22.15x	--	HK$1.84B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.